Dr. Nicole Nelson explores the risk factors connected to breast cancer development and outlines recommendations, therapeutics and testing available to clinicians for prevention.
Carla Wrenn, naturopath and educator, provides us with her insights into the role the integrative practitioner may play in supporting the oncology patient holistically.
Carla Wrenn, naturopath and educator, provides us with her insights into the role the integrative practitioner may play in supporting the oncology patient holistically.
Beth Bundy takes us through oestrogen metabolism and some of the controversial research surrounding oestrogen metabolites and cancer risk.
Naturopath Tanya Wells discusses the full gamut of ways to support cancer patients once they have finished treatment.
Dr Isaac Eliaz discusses how Galectin-3 is implicated in disease development, as well as the research and ramifications of using modfied citrus protein in the treatment of various disease states, including sepsis, cancer, and autoimmunity.
Tanya Wells discusses the role of oestrogen in ER+ breast cancer, taking us through oestrogen clearance, genetics, how to support clients with this type of cancer, and how to prevent reoccurrence after remission.
What does the evidence say about using medicinal cannabis in people with cancer?
In this episode, naturopath and researcher Danielle Brown discusses her research in this area.
